L Kamesh, JM Heward, JM Williams, SCL … - Rheumatology, 2009 - Br Soc Rheumatology Add to CiteULike Add to Connotea Add to Del.icio.us What's this? ... 1 Renal
Unit, University Hospitals Birmingham NHS Foundation Trust, 2 Division of
Immunity and Infection, The Medical School, University of Birmingham, ... Related articles - All 3 versions
L Kamesh, JM Heward, JM Williams, SCL … - Rheumatology - Br Soc Rheumatology Objective. To investigate whether single nucleotide polymorphisms (SNPs) within
cytotoxic T-lymphocyte antigen-4 (CTLA-4) are associated with ANCA-associated
small vessel vasculitis (SVV). Methods. The CTLA-4 CT60 (exon 4), þ49 ... Related articles
M von Herrath, GT Nepom, B Coalition - European Journal of Immunology, 2009 - interscience.wiley.com Type 1 diabetes (T1D) occurs when the immune system attacks the
insulin-producing beta cells located in the islets of Langerhans within the
pancreas. Animal models have played a prominent role in developing an ... Related articles - All 2 versions
D Bresson, M Fradkin, Y Manenkova, D … - Molecular Therapy, 2009 - nature.com To enhance efficacy of forthcoming type 1 diabetes (T1D) clinical trials,
combination therapies (CTs) are envisaged. In this study, we showed that
efficacy of a CT, using anti-CD3 antibody and glutamic acid decarboxylase ... Related articles - All 3 versions